{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:56:04Z","timestamp":1792511764060,"version":"4.5.0"},"reference-count":40,"publisher":"Bentham Science Publishers Ltd.","issue":"4","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CPB"],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:sec>\n<jats:title>Introduction:<\/jats:title>\n<jats:p>The objective of the reported work was to develop Montelukast sodium\n(MS) solid lipid nanoparticles (MS-SLNs) to ameliorate its oral bio-absorption. Herein, the highpressure\nhomogenization (HPH) principle was utilized for the fabrication of MS-SLNs.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Method:<\/jats:title>\n<jats:p>The study encompasses a 23 full factorial statistical design approach where mean particle\nsize (Y1) and percent entrapment efficiency (Y2) were screened as dependent variables while, the\nconcentration of lipid (X1), surfactant (X2), and co-surfactant (X3) were screened as independent\nvariables. The investigation of MS-SLNs by DSC and XRD studies unveiled the molecular\ndispersion of MS into the SLNs while TEM study showed the smooth surface of developed MSSLNs.\nThe optimized MS-SLNs exhibited mean particle size (MPS) = 115.5 \u00b1 1.27 nm,\npolydispersity index (PDI) = 0.256 \u00b1 0.04, zeta potential (\u03b6) = -21.9 \u00b1 0.32 mV and entrapment\nefficiency (EE) = 90.97 \u00b1 1.12 %. The In vivo pharmacokinetic study performed in Albino Wistar\nrats revealed 2.87-fold increments in oral bioavailability.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>The accelerated stability studies of optimized formulation showed good physical and\nchemical stability. The shelf life estimated for the developed MS-SLN was found to be 22.38\nmonths.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>At the outset, the developed MS-SLNs formulation showed a significant increment\nin oral bioavailability and also exhibited excellent stability in exaggerated storage conditions.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0113892010300965240612054349","type":"journal-article","created":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T07:07:32Z","timestamp":1719385652000},"page":"576-590","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Design of Optimized Solid Lipid Nanoparticles of Montelukast Sodium and Assessment of Oral Bioavailability in Experimental Model"],"prefix":"10.2174","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4750-9384","authenticated-orcid":true,"given":"Pankaj","family":"Dangre","sequence":"first","affiliation":[{"name":"Department of Pharmaceutics, K.K. Wagh College of Pharmacy, Nashik-422201, Maharashtra, India"},{"name":"Department of Industrial Pharmacy &amp; Quality Assurance, R. C. Patel Institute of Pharmaceutical Education and Research, Shirpur-425405, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paresh","family":"Wankhede","sequence":"additional","affiliation":[{"name":"Department of Industrial Pharmacy &amp; Quality Assurance, R. C. Patel Institute of Pharmaceutical Education and Research, Shirpur-425405, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kailas","family":"Moravkar","sequence":"additional","affiliation":[{"name":"Department of Industrial Pharmacy &amp; Quality Assurance, R. C. Patel Institute of Pharmaceutical Education and Research, Shirpur-425405, Maharashtra, India"},{"name":"Principal Research Engineer, Regeron Inc., Chuncheon, Gangwon-do, 24253, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohan","family":"Kalaskar","sequence":"additional","affiliation":[{"name":"Department of Pharmacognosy, R. C. Patel Institute of Pharmaceutical Education and Research, Shirpur-425405, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atish","family":"Mundada","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, SNJBs SSDJ College of Pharmacy, Neminagar,\nChandwad-423101, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shailesh","family":"Chalikwar","sequence":"additional","affiliation":[{"name":"Department of Industrial Pharmacy &amp; Quality Assurance, R. C. Patel Institute of Pharmaceutical Education and Research, Shirpur-425405, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.2147\/DDDT.S298355","volume":"15","author":"Li W.","year":"2021","unstructured":"Li W.; Wang Y.; Pei Y.; Xia Y.; Pharmacokinetics and bioequivalence evaluation of two montelukast sodium chewable tablets in healthy chinese volunteers under fasted and fed conditions. Drug Des Devel Ther  2021,15,1091-1099","journal-title":"Drug Des Devel Ther"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.3389\/fphar.2020.01344","volume":"11","author":"Barr\u00e9 J.","year":"2020","unstructured":"Barr\u00e9 J.; Sabatier J.M.; Annweiler C.; Montelukast drug may improve COVID-19 prognosis: A review of evidence. Front Pharmacol  2020,11(9),1344","journal-title":"Front Pharmacol"},{"key":"ref=3","first-page":"405","volume":"50","author":"Popova T.M.","year":"2018","unstructured":"Popova T.M.; Ivanova S.A.; Dimitrov M.V.; Characterization and drug release from extended-release matrix pellets with montelukast sodium. Izv Him  2018,50(3),405-410","journal-title":"Izv Him"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1208\/s12249-020-01825-7","volume":"21","author":"Martir J.","year":"2020","unstructured":"Martir J.; Flanagan T.; Mann J.; Fotaki N.; In vivo predictive dissolution testing of montelukast sodium formulations administered with drinks and soft foods to infants. AAPS PharmSciTech  2020,21(7),282","journal-title":"AAPS PharmSciTech"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1208\/s12249-020-01722-z","volume":"21","author":"Martir J.","year":"2020","unstructured":"Martir J.; Flanagan T.; Mann J.; Fotaki N.; Impact of food and drink administration vehicles on paediatric formulation performance: Part 1\u2014effects on solubility of poorly soluble drugs. AAPS PharmSciTech  2020,21(5),177","journal-title":"AAPS PharmSciTech"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"587997","DOI":"10.3389\/fmolb.2020.587997","volume":"7","author":"Scioli Montoto S.","year":"2020","unstructured":"Scioli Montoto S.; Muraca G.; Ruiz M.E.; Solid lipid nanoparticles for drug delivery: Pharmacological and biopharmaceutical aspects. Front Mol Biosci  2020,7(October),587997","journal-title":"Front Mol Biosci"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3390\/pharmaceutics10040191","volume":"10","author":"Mishra V.","year":"2018","unstructured":"Mishra V.; Bansal K.; Verma A.; Yadav N.; Thakur S.; Sudhakar K.; Rosenholm J.; Solid lipid nanoparticles: Emerging colloidal nano drug delivery systems. Pharmaceutics  2018,10(4),191","journal-title":"Pharmaceutics"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"847","DOI":"10.3390\/nano10050847","volume":"10","author":"Deng S.","year":"2020","unstructured":"Deng S.; Gigliobianco M.R.; Censi R.; Di Martino P.; Polymeric nanocapsules as nanotechnological alternative for drug delivery system: Current status, challenges and opportunities. Nanomaterials  2020,10(5),847","journal-title":"Nanomaterials"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1007\/s13346-021-01024-2","volume":"12","author":"\u0110or\u0111evi\u0107 S.","year":"2022","unstructured":"\u0110or\u0111evi\u0107 S.; Gonzalez M.M.; Conejos-S\u00e1nchez I.; Carreira B.; Pozzi S.; Ac\u00farcio R.C.; Fainaro S.R.; Florindo H.F.; Vicent M.J.; Current hurdles to the translation of nanomedicines from bench to the clinic. Drug Deliv Transl Res  2022,12(3),500-525","journal-title":"Drug Deliv Transl Res"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"26777","DOI":"10.1039\/D0RA03491F","volume":"10","author":"Duan Y.","year":"2020","unstructured":"Duan Y.; Dhar A.; Patel C.; Khimani M.; Neogi S.; Sharma P.; Siva Kumar N.; Vekariya R.L.; A brief review on solid lipid nanoparticles: Part and parcel of contemporary drug delivery systems. RSC Advances  2020,10(45),26777-26791","journal-title":"RSC Advances"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"4781","DOI":"10.3390\/molecules25204781","volume":"25","author":"Duong V.A.","year":"2020","unstructured":"Duong V.A.; Nguyen T.T.L.; Maeng H.J.; Preparation of Solid lipid nanoparticles and nanostructured lipid carriers for drug delivery and the effects of preparation parameters of solvent injection method. Molecules  2020,25(20),4781","journal-title":"Molecules"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.2147\/IJN.S155593","volume":"13","author":"Ganesan P.","year":"2018","unstructured":"Ganesan P.; Ramalingam P.; Karthivashan G.; Ko Y.T.; Choi D.K.; Recent developments in solid lipid nanoparticle and surface-modified solid lipid nanoparticle delivery systems for oral delivery of phyto-bioactive compounds in various chronic diseases. Int J Nanomedicine  2018,13,1569-1583","journal-title":"Int J Nanomedicine"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"100024","DOI":"10.1016\/j.fhfh.2021.100024","volume":"1","author":"Sakellari G.I.","year":"2021","unstructured":"Sakellari G.I.; Zafeiri I.; Batchelor H.; Spyropoulos F.; Formulation design, production and characterisation of solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for the encapsulation of a model hydrophobic active. Food Hydrocoll Health  2021,1(August),100024","journal-title":"Food Hydrocoll Health"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"580118","DOI":"10.3389\/fchem.2021.580118","volume":"9","author":"Dhiman N.","year":"2021","unstructured":"Dhiman N.; Awasthi R.; Sharma B.; Kharkwal H.; Kulkarni G.T.; Lipid nanoparticles as carriers for bioactive delivery. Front Chem  2021,9(April),580118","journal-title":"Front Chem"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"568","DOI":"10.3390\/ph15050568","volume":"15","author":"Unnisa A.","year":"2022","unstructured":"Unnisa A.; Chettupalli A.K.; Al Hagbani T.; Khalid M.; Jandrajupalli S.B.; Chandolu S.; Hussain T.; Development of dapagliflozin solid lipid nanoparticles as a novel carrier for oral delivery: Statistical design, optimization, in-vitro and in-vivo characterization, and evaluation. Pharmaceuticals  2022,15(5),568","journal-title":"Pharmaceuticals"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"533","DOI":"10.3390\/pharmaceutics14030533","volume":"14","author":"Jacob S.","year":"2022","unstructured":"Jacob S.; Nair A.B.; Shah J.; Gupta S.; Boddu S.H.S.; Sreeharsha N.; Joseph A.; Shinu P.; Morsy M.A.; Lipid nanoparticles as a promising drug delivery carrier for topical ocular therapy\u2014an overview on recent advances. Pharmaceutics  2022,14(3),533","journal-title":"Pharmaceutics"},{"key":"ref=17","doi-asserted-by":"crossref","first-page":"e0203405","DOI":"10.1371\/journal.pone.0203405","volume":"13","author":"El-Say K.M.","year":"2018","unstructured":"El-Say K.M.; Hosny K.M.; Optimization of carvedilol solid lipid nanoparticles: An approach to control the release and enhance the oral bioavailability on rabbits. PloS one,  2018,13(8),e0203405","journal-title":"PloS one,"},{"key":"ref=18","first-page":"1","volume":"0","author":"Kuncahyo I.","year":"2021","unstructured":"Kuncahyo I.; Choiri S.; Fudholi A.; Martien R.; Rohman A.; Development of pitavastatin-loaded super-saturable self-nano emulsion: A continues screening and optimization approach using statistical technique. J Dispers Sci Technol  2021,0(0),1-10","journal-title":"J Dispers Sci Technol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"129","DOI":"10.4103\/0975-1483.100016","volume":"4","author":"Priyanka K.","year":"2012","unstructured":"Priyanka K.; Hasan A.S.A.; Preparation and evaluation of montelukast sodium loaded solid lipid nanoparticles. J Young Pharm  2012,4(3),129-137","journal-title":"J Young Pharm"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.ejpb.2014.05.019","volume":"88","author":"Patil-Gadhe A.","year":"2014","unstructured":"Patil-Gadhe A.; Pokharkar V.; Montelukast-loaded nanostructured lipid carriers: Part I Oral bioavailability improvement. Eur J Pharm Biopharm  2014,88(1),160-168","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=21","doi-asserted-by":"crossref","first-page":"101545","DOI":"10.1016\/j.jddst.2020.101545","volume":"56","author":"Gurumukhi V.C.","year":"2019","unstructured":"Gurumukhi V.C.; Bari S.B.; Fabrication of efavirenz loaded nano-formulation using quality by design (QbD) based approach: Exploring characterizations and in vivo safety. J Drug Deliv Sci Technol  2019,56(11),101545","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3390\/pharmaceutics14010131","volume":"14","author":"Alajami H.N.","year":"2022","unstructured":"Alajami H.N.; Fouad E.A.; Ashour A.E.; Kumar A.; Yassin A.E.B.; Celecoxib-loaded solid lipid nanoparticles for colon delivery: Formulation optimization and in vitro assessment of anti-cancer activity. Pharmaceutics  2022,14(1),131","journal-title":"Pharmaceutics"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s13204-017-0547-1","volume":"7","author":"Bhalekar M.","year":"2017","unstructured":"Bhalekar M.; Upadhaya P.; Madgulkar A.; Formulation and characterization of solid lipid nanoparticles for an anti-retroviral drug darunavir. Appl Nanosci  2017,7(1-2),47-57","journal-title":"Appl Nanosci"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s43094-020-00051-z","volume":"6","author":"Nagaraj B.","year":"2020","unstructured":"Nagaraj B.; Tirumalesh C.; Dinesh S.; Narendar D.; Zotepine loaded lipid nanoparticles for oral delivery: development, characterization, and in vivo pharmacokinetic studies. Future J Pharm Sci  2020,6(1),37","journal-title":"Future J Pharm Sci"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/pharmaceutics13010012","volume":"13","author":"Michael J.","year":"2020","unstructured":"Michael J.; de Sousa B.D.; Conway J.; Labrada G.E.; Obeid R.; Tevini J.; Felder T.; Hutter-Paier B.; Zerbe H.; Paiement N.; Aigner L.; Improved bioavailability of montelukast through a novel oral mucoadhesive film in humans and mice. Pharmaceutics  2020,13(1),12","journal-title":"Pharmaceutics"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1177\/1945892419852576","volume":"33","author":"Kaya Z.","year":"2019","unstructured":"Kaya Z.; Yayla M.; Cinar I.; Celebi D.; Toktay E.; Bayraktutan Z.; Bilici D.; Effect of montelukast, a cysteinyl leukotriene receptor-1 antagonist, on a rat model of acute bacterial sinonasal inflammation. Am J Rhinol Allergy  2019,33(5),559-566","journal-title":"Am J Rhinol Allergy"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.3390\/molecules27041433","volume":"27","author":"Sulaiman S.","year":"2022","unstructured":"Sulaiman S.; Ahmad S.; Naz S.S.; Qaisar S.; Muhammad S.; Alotaibi A.; Ullah R.; Synthesis of copper oxide-based nanoformulations of etoricoxib and montelukast and their evaluation through analgesic, anti-inflammatory, anti-pyretic, and acute toxicity activities. Molecules  2022,27(4),1433","journal-title":"Molecules"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"103581","DOI":"10.1016\/j.jddst.2022.103581","volume":"74","author":"Bibi M.","year":"2022","unstructured":"Bibi M.; Din F.; Anwar Y.; Alkenani N.A.; Zari A.T.; Mukhtiar M.; Abu Zeid I.M.; Althubaiti E.H.; Nazish H.; Zeb A.; Ullah I.; Khan G.M.; Choi H-G.; Cilostazol-loaded solid lipid nanoparticles: Bioavailability and safety evaluation in an animal model. J Drug Deliv Sci Technol  2022,74(August),103581","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"523","DOI":"10.3390\/pharmaceutics13040523","volume":"13","author":"Nair A.","year":"2021","unstructured":"Nair A.; Shah J.; Al-Dhubiab B.; Jacob S.; Patel S.; Venugopala K.; Morsy M.; Gupta S.; Attimarad M.; Sreeharsha N.; Shinu P.; Clarithromycin solid lipid nanoparticles for topical ocular therapy: Optimization, evaluation and in vivo studies. Pharmaceutics  2021,13(4),523","journal-title":"Pharmaceutics"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"103716","DOI":"10.1016\/j.apt.2022.103716","volume":"33","author":"Dangre P.V.","year":"2022","unstructured":"Dangre P.V.; Shinde S.B.; Surana S.J.; Jain P.G.; Chalikwar S.S.; Development and exploration on flowability of solid self-nanoemulsifying drug delivery system of morin hydrate. Adv Powder Technol  2022,33(8),103716","journal-title":"Adv Powder Technol"},{"key":"ref=31","first-page":"1","volume":"0","author":"Taleuzzaman M.","year":"2021","unstructured":"Taleuzzaman M.; Sartaj A.; Gupta K.D.; Gilani S.J.; Mohd M.A.; Phytosomal gel of Manjistha extract (MJE) formulated and optimized with central composite design of Quality by Design (QbD). J Dispers Sci Technol  2021,0(0),1-9","journal-title":"J Dispers Sci Technol"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1021\/acschemneuro.8b00510","volume":"10","author":"Sadegh Malvajerd S.","year":"2019","unstructured":"Sadegh Malvajerd S.; Azadi A.; Izadi Z.; Kurd M.; Dara T.; Dibaei M.; Zadeh S.M.; Javar A.H.; Hamidi M.; Brain delivery of curcumin using solid lipid nanoparticles and nanostructured lipid carriers: Preparation, optimization, and pharmacokinetic evaluation. ACS Chem Neurosci  2019,10(1),728-739","journal-title":"ACS Chem Neurosci"},{"key":"ref=33","doi-asserted-by":"crossref","first-page":"112607","DOI":"10.1016\/j.lwt.2021.112607","volume":"154","author":"Zhou Y.","year":"2021","unstructured":"Zhou Y.; Yue W.; Luo Y.; Luo Q.; Liu S.; Chen H.; Preparation and stability characterization of soybean protein isolate\/sodium alginate complexes-based nanoemulsions using high-pressure homogenization. LWT  2021,154(10),112607","journal-title":"LWT"},{"key":"ref=34","first-page":"1","volume":"0","author":"Dangre P.","year":"2023","unstructured":"Dangre P.; Sonawane K.; Moravkar K.; Pethe A.; Chalikwar S.; Borse V.; Design of layer-by-layer lipid-polymer hybrid nanoparticles to elicit oral bioavailability of buspirone hydrochloride. Int J Polym Mater  2023,0(0),1-11","journal-title":"Int J Polym Mater"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1016\/j.apsb.2020.12.022","volume":"11","author":"Zhang Z.","year":"2021","unstructured":"Zhang Z.; Lu Y.; Qi J.; Wu W.; An update on oral drug delivery via intestinal lymphatic transport. Acta Pharm Sin B  2021,11(8),2449-2468","journal-title":"Acta Pharm Sin B"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1038\/s41467-020-15889-3","volume":"11","author":"Rasmussen M.K.","year":"2020","unstructured":"Rasmussen M.K.; Pedersen J.N.; Marie R.; Size and surface charge characterization of nanoparticles with a salt gradient. Nat Commun  2020,11(1),2337","journal-title":"Nat Commun"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1080\/10942912.2015.1083576","volume":"19","author":"Slettengren K.","year":"2016","unstructured":"Slettengren K.; Xanthakis E.; Ahrn\u00e9 L.; Windhab E.J.; Flow properties of spices measured with powder flow tester and ring shear tester-XS. Int J Food Prop  2016,19(7),1475-1482","journal-title":"Int J Food Prop"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1007\/s13346-021-01083-5","volume":"12","author":"Gurumukhi V.C.","year":"2022","unstructured":"Gurumukhi V.C.; Bari S.B.; Development of ritonavir-loaded nanostructured lipid carriers employing quality by design (QbD) as a tool: Characterizations, permeability, and bioavailability studies. Drug Deliv Transl Res  2022,12(7),1753-1773","journal-title":"Drug Deliv Transl Res"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"111073","DOI":"10.1016\/j.colsurfb.2020.111073","volume":"193","author":"Diwan R.","year":"2020","unstructured":"Diwan R.; Ravi P.R.; Pathare N.S.; Aggarwal V.; Pharmacodynamic, pharmacokinetic and physical characterization of cilnidipine loaded solid lipid nanoparticles for oral delivery optimized using the principles of design of experiments. Colloids Surf B Biointerfaces  2020,193(April),111073","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.bfopcu.2013.05.002","volume":"51","author":"Chaudhary H.","year":"2013","unstructured":"Chaudhary H.; Gauri S.; Rathee P.; Kumar V.; Development and optimization of fast dissolving oro-dispersible films of granisetron HCl using Box\u2013Behnken statistical design. Bull Fac Pharm Cairo Univ  2013,51(2),193-201","journal-title":"Bull Fac Pharm Cairo Univ"}],"container-title":["Current Pharmaceutical Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113892010300965240612054349","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/231279\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113892010300965240612054349","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T12:59:31Z","timestamp":1739451571000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/231279\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0113892010300965240612054349","relation":{},"ISSN":["1389-2010"],"issn-type":[{"value":"1389-2010","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2023-12-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-01","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-08","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-01-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}